HPV Prophylactic Vaccine after Surgical Treatment of Cervical Lesions
IPVS educational webinar: HPV Prophylactic Vaccine after Surgical Treatment of Cervical Lesions Wednesday, 10 July 2024 16:00 CEST (Geneva) / 10:00 EDT (New York) Topic: Participate in this free webinar where our expert panel will explore critical topics including the efficacy of vaccination against original vs. new HPV types post-surgery, diseases with solid evidence […]
The Future of HPV Research
IPVS educational webinar: The Future of HPV Research Wednesday, 26 June 2024 17:30 CEST (Geneva) / 11:30 EDT (New York) Topic: With advancements over the past decades, we have gained clarity on many facets of HPV infection, paving the way for effective diagnostic and preventive measures against HPV-related diseases. In this webinar, we aim […]
HPV Screening Tests: How to Make the Best Decision for Your Program
IPVS educational webinar – HPV Screening Tests: How to Make the Best Decision for Your Program Tuesday, 18 February 2025 16:00 CET (Geneva) / 10:00 EST (New York) Topic: Participate in this free educational webinar to discover how to make informed decisions about HPV screening strategies to enhance cervical cancer prevention efforts. This post-IPVC 2024 […]
Behavioral & Implementation Science in Action: A Case Study of the HPV Vaccine Task Force in Ontario, Canada
IPVS educational webinar: Behavioral & Implementation Science in Action: A Case Study of the HPV Vaccine Task Force in Ontario, Canada Tuesday, 18 March 2025 17:30 CET (Geneva) / 11:30 EST (New York) Topic: Discover how innovative approaches in behavioral and implementation science are transforming HPV immunization efforts in Ontario. Join our experts as […]
Controversies in Anal Cancer Screening
IPVS educational webinar: Controversies in Anal Cancer Screening Wednesday, 9 April 2025 16:00 CET (Geneva) / 10:00 EST (New York) Topic: Discover the latest insights and debates surrounding anal cancer screening in this webinar. Our expert panel will discuss key challenges in identifying high-risk populations, the pros and cons of various screening methods, and […]